Medelis: OncologyCRO is a specialty oncology contract research organization (CRO) that offers a wide range of oncology drug development services to biotech and pharma sponsors who are seeking rapid drug development. Led by a highly-skilled clinical team and oncology drug development thought-leaders, Medelis provides expertise and support throughout the entire drug development process. Their services include study design, study launch, study management, medical writing, study rescue, and drug development consulting.

With deep operational oncology experience and extensive investigator relationships, Medelis is able to quickly launch studies and access the right patients. They prioritize relationships and aim to be an extension of their clients' teams, providing decision support, streamlined trial planning, and management. As a specialty oncology CRO, Medelis has the expertise, focus, and agility to deliver accurate results quickly.

Their value lies in their deep oncology expertise at every level of a trial, flexible and collaborative approach, world-class drug development expertise, and cost certainty. With over 20 years of experience in oncology indications and more than 150 projects completed, Medelis is a trusted partner in oncology drug development